Shinobi Therapeutics Announces the Appointment of Dr. Laurent Fischer as Chair of its Board of Directors [Yahoo! Finance]
Adverum Biotechnologies, Inc. (ADVM)
Last adverum biotechnologies, inc. earnings: 3/12 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adverum.gcs-web.com/investor-overview
Company Research
Source: Yahoo! Finance
focused on developing and commercializing breakthrough therapies, including Adverum Biotechnologies, recently acquired by Eli Lilly Shinobi prepares to advance two immune evasive iPSC therapies toward the clinic in 2026, and today announces its first data presentation at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting SAN FRANCISCO and KYOTO, Japan Nov. 7, 2025 /PRNewswire/ -- Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS therapies, today announced the appointment of Laurent Fischer, MD, as its first independent Chair of the Board of Directors, alongside the company's first data presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting taking place in National Harbor, MD from November 5-9, 2025. These milestones collectively reflect Shinobi's continued momentum as it advances its oncology and autoimmune pipeline toward clinical entry in 2026. Shinobi Therapeutics Logo (PRNewsfoto/Shinobi Th
Show less
Read more
Impact Snapshot
Event Time:
ADVM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADVM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADVM alerts
High impacting Adverum Biotechnologies, Inc. news events
Weekly update
A roundup of the hottest topics
ADVM
News
- Adverum Reminds Stockholders to Tender their Shares into the Offer by LillyGlobeNewswire
- Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their RightsPR Newswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-HOUS, ADVM, HBAN, and COMPPR Newswire
- Adverum Biotechnologies (NASDAQ:ADVM) had its "neutral" rating reaffirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, down previously from $30.00.MarketBeat
- Adverum Biotechnologies (NASDAQ:ADVM) was given a new $5.50 price target on by analysts at Mizuho.MarketBeat
ADVM
Earnings
- 11/12/25 - Miss
ADVM
Sec Filings
- 12/5/25 - Form 3
- 12/4/25 - Form 8-K
- 12/3/25 - Form 4
- ADVM's page on the SEC website